Tygh Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-56,334
| Closed | -$5.05M | – | 91 |
|
|
2020
Q4 | $5.05M | Sell |
56,334
-74,192
| -57% | -$6.65M | 0.79% | 58 |
|
|
2020
Q3 | $13.5M | Sell |
130,526
-12,870
| -9% | -$1.33M | 2.56% | 2 |
|
|
2020
Q2 | $11.3M | Buy |
143,396
+664
| +0.5% | +$52.5K | 2.36% | 6 |
|
|
2020
Q1 | $8.26M | Buy |
142,732
+25,570
| +22% | +$1.48M | 1.85% | 19 |
|
|
2019
Q4 | $6.32M | Sell |
117,162
-181,326
| -61% | -$9.78M | 1.04% | 45 |
|
|
2019
Q3 | $15.6M | Buy |
298,488
+202,527
| +211% | +$10.6M | 2.77% | 4 |
|
|
2019
Q2 | $4.64M | Buy |
+95,961
| New | +$4.64M | 0.79% | 60 |
|